Zymeworks Inc. is a privately held Canadian corporation headquartered in Vancouver, British Columbia.  Zymeworks Biopharmaceuticals, Inc., Zymeworks’ wholly owned subsidiary, is incorporated and located in Seattle, Washington.

Zymeworks’ investors include financial institutions and its strategic pharmaceuticals, as well as family offices and individual investors from across the globe. 

More information is available upon request at ir@zymeworks.com.